Management of Borderline Right Kidney Atrophy with Cortical Thinning

Initial Diagnostic Evaluation

The European Society of Cardiology recommends measuring renal length precisely on ultrasound, where a kidney <7 cm indicates non-viability, while >8 cm suggests viability and potential for intervention 2
The European Society of Cardiology suggests evaluating cortical thickness, where distinct cortex >0.5 cm indicates viability, while loss of corticomedullary differentiation suggests irreversible damage 2
The American Urological Association recommends obtaining serum creatinine and calculating eGFR to establish baseline renal function, particularly if bilateral cortical abnormalities are present 3, 1
The European Society of Cardiology recommends checking urinalysis for proteinuria, where albumin-creatinine ratio <20 mg/mmol suggests viability, while >30 mg/mmol indicates non-viability 2
The European Society of Cardiology suggests measuring renal resistance index by Doppler ultrasound, where values <0.8 suggest viable kidney, while >0.8 indicates poor prognosis 2

The European Society of Cardiology recommends optimizing medical therapy first with antihypertensive agents, statins, and antiplatelet therapy for atherosclerotic RAS with viable kidney (>8 cm, cortex >0.5 cm, RI <0.8) 2
The European Society of Cardiology suggests considering revascularization only if high-risk features are present, such as rapidly progressive hypertension, rapidly declining renal function, flash pulmonary edema, or solitary kidney 2
The European Society of Cardiology recommends avoiding nephrotoxic agents, including NSAIDs and certain contrast media, when possible 5

The European Society of Cardiology recommends duplex ultrasound as the preferred modality for serial monitoring, assessing renal size, cortical thickness, and vascular parameters 2, 4
The European Society of Cardiology suggests reassessing conservatively managed RAS patients at 1 month and then every 12 months, or when new symptoms arise 2
The American Urological Association recommends serial measurement of serum creatinine to detect progressive decline in function 1
The European Society of Cardiology recommends monitoring for proteinuria, as increasing levels suggest worsening kidney damage 2
The European Society of Cardiology suggests blood pressure monitoring with both office and out-of-office measurements 2